{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:01:57Z","timestamp":1758844917801,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3749,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1111\/j.1523-1755.2005.09813.x","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T12:09:43Z","timestamp":1123762183000},"page":"S69-S75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S98","title":["Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world"],"prefix":"10.1016","volume":"68","author":[{"given":"Ricardo","family":"Correa-Rotter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Gonzalez-Michaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2307\/3349375","article-title":"The epidemiologic transition: A key of the epidemiology of population change","volume":"49","author":"Omran","year":"1971","journal-title":"Milibank Mem Fund Q"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.CIR.97.6.596","article-title":"Emerging epidemic of cardiovascular disease in developing countries","volume":"97","author":"Reddy","year":"1998","journal-title":"Circulation"},{"year":"1993","series-title":"World Development Report: Investing in Health New York, Oxford University Press","author":"World Bank","key":"10.1111\/j.1523-1755.2005.09813.x_bb0020"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1079\/PHN2001282","article-title":"Epidemiological and nutritional transition in Mexico: Rapid increase of non-communicable chronic diseases and obesity","volume":"5","author":"Rivera","year":"2002","journal-title":"Public Health Nutr"},{"first-page":"17","year":"1999","author":"Partida Bush","key":"10.1111\/j.1523-1755.2005.09813.x_bb0030"},{"year":"1994","series-title":"Global Comparative Assessments in the Health Sector Geneva, Switzerland, World Health Organization","author":"Murray","key":"10.1111\/j.1523-1755.2005.09813.x_bb0035"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0040","series-title":"Disease Control Priorities in Developing Countries New York, Oxford University Press","first-page":"577","article-title":"Cardiovascular disease","author":"Pearson","year":"1993"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oxfordjournals.bmb.a011519","article-title":"Mortality from smoking worldwide","volume":"52","author":"Peto","year":"1996","journal-title":"Br Med Bull"},{"year":"1996","series-title":"Tobacco or Health? First Global Status Report Geneva, Switzerland, World Health Organization","author":"World Health Organization","key":"10.1111\/j.1523-1755.2005.09813.x_bb0050"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1753-4887.1994.tb01460.x","article-title":"The nutrition transition in low-income countries: An emerging crisis","volume":"52","author":"Popkin","year":"1994","journal-title":"Nutr Rev"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0060","series-title":"Diet, Nutrition and Chronic Disease: Lessons from Contrasting Worlds Chichester, United Kingdom, Wiley","first-page":"173","article-title":"The public health impact of globalization of food trade","author":"Lang","year":"1997"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1753-4887.1997.tb01593.x","article-title":"The nutrition transition: New trends in the global diet","volume":"55","author":"Drewnowski","year":"1997","journal-title":"Nutr Rev"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0070","first-page":"36","article-title":"The challenge of hypertension and atherosclerotic cardiovascular disease in economically developing countries","volume":"4","author":"Whelton","year":"1995","journal-title":"High Blood Press"},{"year":"2000","series-title":"Direcci\u00f3n General de Epidemiolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n M\u00e9xico, D.F, Secretar\u00eda de Salud","author":"Encuesta Nacional de Enfermedades Cronicas 2000","key":"10.1111\/j.1523-1755.2005.09813.x_bb0075"},{"year":"1993","series-title":"Direcci\u00f3n General de Epidemiolog\u00eda, Instituto Nacional de la Nutrici\u00f3n M\u00e9xico, D.F., Secretar\u00eda de Salud","author":"Encuesta Nacional de Enfermedades Cronicas 1993","key":"10.1111\/j.1523-1755.2005.09813.x_bb0080"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0085","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00125-004-1464-x","article-title":"Type 2 diabetes mellitus\u2014Genes or intrauterine environment? An embryo transfer paradigm in rats","volume":"47","author":"Gill-Randall","year":"2004","journal-title":"Diabetologia"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0090","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/diabetes.53.5.1181","article-title":"Genetic studies of the etiology of type 2 diabetes in Pima Indians: Hunting for pieces to a complicated puzzle","volume":"53","author":"Baier","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0095","first-page":"2","article-title":"La Diabetes en M\u00e9xico","author":"Velazquez","year":"1999","journal-title":"Bolet\u00edn Epidemiol\u00f3gico en Espa\u00f1ol Panamerican Health Organization available at:http:\/\/www.alertnet.org\/thenews\/newsdesk\/N24404782.htm., Reuters, accessed August 24"},{"journal-title":"Report from the Mexican Minister of Health","article-title":"Reuters AlertNet: Diabetes now Mexico's leading cause of death","year":"2004","key":"10.1111\/j.1523-1755.2005.09813.x_bb0100"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2796.2000.00625.x","article-title":"Globalization, coca-colonization and the chronic disease epidemic: Can the doomsday scenario be averted?","volume":"247","author":"Zimmet","year":"2000","journal-title":"J Intern Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/dmr.5610080406","article-title":"The economic costs of NIDDM","volume":"8","author":"Songer","year":"1992","journal-title":"Diabetes Metabol Rev"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0115","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1523-1755.2001.00020.x","article-title":"Diabetic nephropathy: Prevention and treatment","volume":"60","author":"Parving","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0120","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes 1995-2025, prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2005.09813.x_bb0125","first-page":"S3","article-title":"The need for tighter control of cardiovascular risk factors in diabetic patients","volume":"21","author":"Viberti","year":"2003","journal-title":"J Hypertens"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0130","doi-asserted-by":"crossref","first-page":"F442","DOI":"10.1152\/ajprenal.00247.2003","article-title":"Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus. A temporal perspective","volume":"286","author":"Lane","year":"2004","journal-title":"Am J Physiol Renal"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0135","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinte.158.9.998","article-title":"Main risk factors for nephropathy in type 2DM are plasma cholesterol levels, mean blood pressure, and hyperglycemia","volume":"158","author":"Ravid","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diab.35.5.530","article-title":"Design and methodologic considerations for the feasibility phase. The DCCT Research Group","volume":"35","author":"The Diabetes Control and Complications Trial (DCCT)","year":"1986","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0145","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group","volume":"47","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 80","key":"10.1111\/j.1523-1755.2005.09813.x_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1523-1755.61.s80.5.x","article-title":"Slowing the progression of renal failure","volume":"61","author":"Praga","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0155","series-title":"Cochrane Database Syst Rev (2)","first-page":"CD002181","article-title":"Protein restriction for diabetic renal disease","author":"Waugh","year":"2000"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0160","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/ndt\/14.6.1445","article-title":"The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: A randomized trial","volume":"14","author":"Pijls","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0272-6386(99)70299-4","article-title":"Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine","volume":"33","author":"Fassi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"United Kingdom Prospective Diabetes Study Group (UKPDS)","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00041552-200401000-00011","article-title":"Evidence for increased cardiovascular risk in patients with chronic kidney disease","volume":"13","author":"Coresh","year":"2004","journal-title":"Curr Op Nephrol Hypertens"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00041552-200401000-00012","article-title":"New insights into the significance of microalbuminuria","volume":"13","author":"MacIsaac","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0185","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ije\/dyh008","article-title":"Microabuminuria independently predicts all-cause and cardiovascular mortality in British population: The European Prospectiva Investigation into Cancer in Norfolk (EPIC-Norfolk) population study","volume":"33","author":"Yuyun","year":"2004","journal-title":"Int J Epidem"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0195","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"for the collaborative Study Group Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0205","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM200109203451209","article-title":"Prevention of end-stage renal disease due to type 2 diabetes","volume":"345","author":"Hostetter","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICROHOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation (HOPE) Study","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0215","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1046\/j.1523-1755.61.s80.6.x","article-title":"An update on the referral pattern of patients with end-stage renal disease","volume":"61","author":"Lameire","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09813.x_bb0225","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.324.7338.652","article-title":"Cost effectiveness of continuing professional development in health care: A critical review of the evidence","volume":"324","author":"Brown","year":"2002","journal-title":"BMJ"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815512684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815512684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:46:55Z","timestamp":1758761215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815512684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":44,"alternative-id":["S0085253815512684"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09813.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"type":"print","value":"0085-2538"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09813.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}